内质网应激在糖尿病角膜内皮功能障碍中的致病作用
研究采用链脲佐菌素诱导的1型糖尿病小鼠和db/db 2型糖尿病小鼠,观察内质网应激与角膜内皮功能障碍的关系,并用内质网应激激动剂毒胡萝卜素、拮抗剂4-苯丁酸、线粒体靶向抗氧化剂SkQ1及活性氧清除剂N-乙酰-L-半胱氨酸干预。结果显示糖尿病小鼠中内质网应激先于角膜内皮形态改变出现,持续内质网应激直接导致正常小鼠角膜水肿和内皮细胞丢失,抑制内质网应激可减轻糖尿病小鼠高眼压处理后的角膜水肿和内皮细胞丢失。
要点
- 糖尿病小鼠中内质网应激的出现先于角膜内皮形态学改变。
- 持续内质网应激直接导致正常小鼠角膜水肿和内皮细胞丢失。
- 抑制内质网应激可减轻糖尿病小鼠高眼压处理后的角膜水肿和内皮细胞丢失。
核心结论
- 高血糖诱导的内质网应激参与糖尿病角膜内皮功能障碍,抑制内质网应激可能通过改善线粒体生物能量学提供治疗潜力。
研究设计与样本
- 研究使用链脲佐菌素诱导的1型糖尿病小鼠和db/db 2型糖尿病小鼠作为糖尿病动物模型。
- 小鼠接受内质网应激激动剂毒胡萝卜素、60-mmHg眼压联合内质网应激拮抗剂4-苯丁酸、线粒体靶向抗氧化剂SkQ1或活性氧清除剂N-乙酰-L-半胱氨酸处理。
- 处理前后测量角膜厚度和内皮细胞密度。
- 人角膜内皮细胞接受高糖处理,伴或不伴4-苯丁酸。
- 通过蛋白质印迹和免疫荧光染色检测角膜内皮相关及内质网应激相关基因表达,使用Agilent Seahorse XFp分析仪测量线粒体生物能量学。
主要发现
- 糖尿病小鼠中内质网应激的出现先于角膜内皮形态学改变。
- 持续内质网应激直接导致正常小鼠角膜水肿和内皮细胞丢失。
- 药物抑制内质网应激足以减轻两种糖尿病小鼠高眼压处理后的角膜水肿和内皮细胞丢失。
- 抑制内质网应激改善了高血糖诱导的线粒体生物能量学缺陷,并改善角膜内皮的屏障和泵功能恢复。
- 与N-乙酰-L-半胱氨酸相比,4-苯丁酸和SkQ1在改善糖尿病小鼠角膜水肿和内皮细胞丢失方面表现更好。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
PURPOSE: Progressive corneal edema and endothelial cell loss represent the major corneal complications observed in diabetic patients after intraocular surgery. However, the underlying pathogenesis and potential treatment remain incompletely understood. METHODS: We used streptozotocin-induced type 1 diabetic mice and db/db type 2 diabetic mice as diabetic animal models. These mice were treated with the endoplasmic reticulum (ER) stress agonist thapsigargin; 60-mmHg intraocular pressure (IOP) with the ER stress antagonist 4-phenylbutyric acid (4-PBA); mitochondria-targeted antioxidant SkQ1; or reactive oxygen species scavenger N-acetyl-l-cysteine (NAC). Corneal thickness and endothelial cell density were measured before and after treatment. Human corneal endothelial cells were treated with high glucose with or without 4-PBA. The expression of corneal endothelial- and ER stress-related genes was detected by western blot and immunofluorescence staining. Mitochondrial bioenergetics were measured with an Agilent Seahorse XFp Analyzer. RESULTS: In diabetic mice, the appearance of ER stress preceded morphological changes in the corneal endothelium. The persistent ER stress directly caused corneal edema and endothelial cell loss in normal mice. Pharmacological inhibition of ER stress was sufficient to mitigate corneal edema and endothelial cell loss in both diabetic mice after high IOP treatment. Mechanistically, inhibiting ER stress ameliorated the hyperglycemia-induced mitochondrial bioenergetic deficits and improved the barrier and pump functional recovery of the corneal endothelium. When compared with NAC, 4-PBA and SkQ1 exhibited better improvement of corneal edema and endothelial cell loss in diabetic mice. CONCLUSIONS: Hyperglycemia-induced ER stress contributes to the dysfunction of diabetic corneal endothelium, and inhibiting ER stress may offer therapeutic potential by improving mitochondrial bioenergetics.
引用
- Chen C, Zhang B, Xue J, et al. Pathogenic Role of Endoplasmic Reticulum Stress in Diabetic Corneal Endothelial Dysfunction. Invest Ophthalmol Vis Sci. 2022. PMID: 35238867. doi:10.1167/iovs.63.3.4
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。